Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events.
O'Malley
Patricia
P
Miami Valley Hospital, Dayton, Ohio, USA. pomalley@mvh.org
D001552:Benzazepines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced; D009483:Neuropsychological Tests; D018722:Nicotinic Agonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D011810:Quinoxalines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D011978:Receptors, Nicotinic / Q000187:drug effects*; D016540:Smoking Cessation; D000068580:Varenicline
D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D011978:Receptors, Nicotinic; D000068580:Varenicline